IMAT Funding Opportunities Published for 2010.
The 2010 IMAT Funding Opportunity Announcements are now published. Please pay attention to the new page requirements for all R21 and R33 applications. More information can be found on the Funding Overview page.

NIH plans to commit at least $80M in 2010 to “bold and highly new innovative research approaches”
The NIH Director’s New Innovator (DP2) Award program aims to support early stage investigators to propose bold and highly innovative new research approaches that have the potential to produce a major impact on broad, important problems in biomedical and behavioral research. More information can be found here.

OBBR Highlighted in Time Magazine's “10 Ideas Changing the World Right Now: What's Next 2009”
The National Cancer Institute's Office of Biorepositories and Biospecimen Research is leading an effort to build the U.S.'s first national biobanking resource. A Time Magazine article recently discussed this effort, naming it one of the "10 ideas changing the world right now." As a formal part of the OBBR, the IMAT program possesses funding opportunities in biospecimen science aimed at supporting this important effort. Read the entire article here .

IMAT Investigator / Technology Wins 2008 “Innovation of the Year” Award
James Landers , a professor of chemistry and mechanical engineering and an associate professor of pathology at the University of Virginia , was recently recognized with the 2008 Innovation Award from the Association for Laboratory Automation (ALA) for his novel Microfluidic Genetic Analysis (MGA) technology.

Two IMAT Technologies Featured in 2 Separate Issues of Science
Two IMAT technologies were recently featured in the journal Science.

IMAT Technology Featured in Nature Nanotechnology
The work of Dr Shanna O Kelley, an international IMAT grantee from the University of Toronto , was recently featured in an article published in the journal, Nature Nanotechnology .

USPTO Approves 8 new patents on IMAT technologies in 2007-2008
IMAT program investigators successfully secured the approval of 8 additional new patents for novel technologies in calendar year 2007 through 2008 from the United States Patent and Trademark Office (USPTO).

2009 IMAT RFAs Released
The 2009 IMAT Request for Applications (RFAs) have been synthesized and released.

IMAT Announces New Affiliated Funding Opportunity Announcement in Biospecimen Integrity and Variability (2008)
As a part of the Biospecimen Research Network of the Office of Biorepositories and Biospecimen Research (OBBR), the IMAT program is pleased to announce the issuance of a new funding opportunity announcement directed at examining the variables associated with human biospecimen integrity.

IMAT Receives 5-Year Reauthorization (2007)
The IMAT program is pleased to announce the renewal of this highly successful and competitive technology development initiative.